Skip to main content
logo
Elixinol Wellness Limited (ASX:EXL)
Australia flag Australia · Delayed Price · Currency is AUD
0.0120
0.00 (0.00%)
Nov 7, 2025, 12:00 PM AEST

Elixinol Wellness Revenue

Elixinol Wellness had revenue of 7.67M AUD in the half year ending June 30, 2025, with 121.85% growth. This brings the company's revenue in the last twelve months to 15.85M, up 36.79% year-over-year. In the year 2024, Elixinol Wellness had annual revenue of 14.96M with 80.87% growth.

Revenue (ttm)
15.85M
Revenue Growth
+36.79%
P/S Ratio
0.21
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.32M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202414.96M6.69M80.87%
Dec 31, 20238.27M1.21M17.21%
Dec 31, 20227.06M-2.28M-24.45%
Dec 31, 20219.34M-5.67M-37.79%
Dec 31, 202015.01M-15.70M-51.13%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited23.73B
Ramsay Health Care17.79B
Sonic Healthcare9.65B
Ansell3.06B
Cochlear2.34B
Regis Healthcare1.16B
Telix Pharmaceuticals1.01B
Neuren Pharmaceuticals218.86M
Revenue Rankings

Elixinol Wellness News

More News